BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15828306)

  • 1. [The prognostic significance of P-glycoprotein in children with acute lymphoblastic leukemia and neuroblastoma].
    De Moerloose B
    Verh K Acad Geneeskd Belg; 2005; 67(1):45-54. PubMed ID: 15828306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
    Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined analysis of P-glycoprotein expression and activity predicts outcome in childhood acute lymphoblastic leukemia.
    De Moerloose B; Swerts K; Benoit Y; Laureys G; Loeys T; Philippé J; Dhooge C
    Pediatr Hematol Oncol; 2003; 20(5):381-91. PubMed ID: 12775536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-glycoprotein (P-170) expression in acute leukemias.
    Abd El-Ghaffar HA; Aladle DA; Farahat SE; Abd El-Hady N
    Hematology; 2006 Feb; 11(1):35-41. PubMed ID: 16522547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia.
    Swerts K; de Moerloose B; Dhooge C; Noens L; Laureys G; Benoit Y; Philippé J
    Leuk Lymphoma; 2004 Nov; 45(11):2221-8. PubMed ID: 15512810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
    Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
    Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.
    Den Boer ML; Zwaan CM; Pieters R; Kazemier KM; Rottier MM; Flens MJ; Scheper RJ; Veerman AJ
    Leukemia; 1997 Jul; 11(7):1078-85. PubMed ID: 9204995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein activity predicts outcome in childhood acute lymphoblastic leukemia.
    Brozek J; Bryl E; Płoszyńska A; Balcerska A; Witkowski JM
    J Pediatr Hematol Oncol; 2009 Jul; 31(7):493-9. PubMed ID: 19564743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of chemotherapy resistance genes in outcome of neuroblastoma.
    de Cremoux P; Jourdan-Da-Silva N; Couturier J; Tran-Perennou C; Schleiermacher G; Fehlbaum P; Doz F; Mosseri V; Delattre O; Klijanienko J; Vielh P; Michon J
    Pediatr Blood Cancer; 2007 Mar; 48(3):311-7. PubMed ID: 16609945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.
    Styczynski J; Wysocki M; Debski R; Czyzewski K; Kolodziej B; Rafinska B; Kubicka M; Koltan S; Koltan A; Pogorzala M; Kurylak A; Olszewska-Slonina D; Balwierz W; Juraszewska E; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Malinowska I; Stanczak E; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Maciejka-Kapuscinska L
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):875-93. PubMed ID: 17671794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors.
    De Moerloose B; Dhooge C; Laureys G; Benoit Y; Demarche M; Devalck C; Plantaz D; Leroy J; Philippé J
    Cytometry; 1999 Oct; 37(2):125-32. PubMed ID: 10486524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is P-glycoprotein a sufficient marker for multidrug resistance in vivo? Immunohistochemical staining for P-glycoprotein in children and adult leukemia: correlation with clinical outcome.
    Kaczorowski S; Ochocka M; Kaczorowska M; Aleksandrowicz R; Matysiakl M; Karwacki M
    Leuk Lymphoma; 1995 Dec; 20(1-2):143-52. PubMed ID: 8750636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive analyses of P-glycoprotein in chronic myeloid leukaemia.
    De Moerloose B; Muylaert A; Gemmel F; Janssens A; Poppe B; Dhooge C; Benoit Y; Van Hove W; Philippé J
    Acta Clin Belg; 2000; 55(4):215-21. PubMed ID: 11036680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of functional assay of multidrug resistance for prediction of chemotherapy outcomes in acute leukemia].
    Ye X; Tan H; Feng Y; Su H; Lai YY; Pang Y
    Ai Zheng; 2003 Aug; 22(8):856-60. PubMed ID: 12917035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
    Willman CL
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal sphingomyelin influences the cellular lipid profile of human lymphoblastic leukemia cells without effect on P-glycoprotein activity.
    Zembruski NC; Nguyen CD; Theile D; Ali RM; Herzog M; Hofhaus G; Heintz U; Burhenne J; Haefeli WE; Weiss J
    Mol Pharm; 2013 Mar; 10(3):1020-34. PubMed ID: 23379426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study.
    Dhooge C; De Moerloose B; Laureys G; Kint J; Ferster A; De Bacquer D; Philippe J; Benoit Y
    Br J Haematol; 1999 Jun; 105(3):676-83. PubMed ID: 10354131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up.
    Kanerva J; Tiirikainen MI; Mäkipernaa A; Riikonen P; Möttönen M; Salmi TT; Krusius T; Saarinen-Pihkala UM
    Pediatr Hematol Oncol; 2001; 18(1):27-36. PubMed ID: 11205837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells.
    Gayet L; Dayan G; Barakat S; Labialle S; Michaud M; Cogne S; Mazane A; Coleman AW; Rigal D; Baggetto LG
    Biochemistry; 2005 Mar; 44(11):4499-509. PubMed ID: 15766280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of P-glycoprotein (P-gp) expression in childhood acute lymphoblastic leukemia. Results of a 6-year prospective study.
    Dhooge C; De Moerloose B
    Adv Exp Med Biol; 1999; 457():11-9. PubMed ID: 10500775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.